Akoya Biosciences, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Akoya Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Akoya Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.35M, a 27.7% increase year-over-year.
  • Akoya Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$50.5M, a 23.3% increase year-over-year.
  • Akoya Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$57.7M, a 12.8% increase from 2022.
  • Akoya Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$66.1M, a 68.2% decline from 2021.
  • Akoya Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$39.3M, a 227% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$57.7M +$8.44M +12.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$66.1M -$26.8M -68.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$39.3M -$27.3M -227% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$12M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.